Keybank National Association OH Sells 3,132 Shares of STERIS plc $STE

Keybank National Association OH lowered its position in STERIS plc (NYSE:STE) by 15.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,051 shares of the medical equipment provider’s stock after selling 3,132 shares during the period. Keybank National Association OH’s holdings in STERIS were worth $4,323,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Steigerwald Gordon & Koch Inc. acquired a new stake in shares of STERIS in the 3rd quarter valued at $25,000. Board of the Pension Protection Fund acquired a new position in STERIS during the fourth quarter worth $25,000. Harbor Investment Advisory LLC increased its position in STERIS by 115.4% during the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 60 shares during the last quarter. Cloud Capital Management LLC bought a new position in STERIS during the third quarter valued at about $29,000. Finally, Geneos Wealth Management Inc. raised its holdings in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the sale, the director owned 705 shares in the company, valued at $167,233.05. This represents a 81.46% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.07% of the stock is currently owned by insiders.

STERIS Stock Performance

NYSE:STE opened at $216.84 on Friday. The firm has a market capitalization of $21.27 billion, a PE ratio of 30.24 and a beta of 1.07. STERIS plc has a 1 year low of $209.98 and a 1 year high of $269.44. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. The firm’s fifty day simple moving average is $226.36 and its 200 day simple moving average is $244.69.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, sell-side analysts anticipate that STERIS plc will post 10.22 EPS for the current year.

Analysts Set New Price Targets

STE has been the subject of several recent analyst reports. Wall Street Zen downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Weiss Ratings downgraded STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, April 16th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.